Table 5.
Plasma Measurements Following 4V Infusions of OT or Vehicle in Female HFD-Fed DBA/2J Mice.
| 4V Treatment | Vehicle | OT |
|---|---|---|
| Leptin (ng/mL) | 5.1 ± 1.4 a | 3.1 ± 0.5 a |
| Insulin (ng/mL) | 2.6 ± 0.4 a | 1.4 ± 0.2 b |
| Glucagon (pmol/L) | 46.1 ± 11.2 a | 46.9 ± 8.7 a |
| FGF-21 (pg/mL) | 1419.1 ± 251.3 a | 1297.8 ± 282 a |
| Irisin (mg/mL) | 5.0 ± 0.2 a | 4.2 ± 0.3 a |
| Adiponectin (mg/mL) | 8.1 ± 0.2 a | 8.4 ± 0.3 a |
| Blood Glucose (mg/dL) | 140 ± 4.3 a | 145.4 ± 4.2 a |
| FFA (mEq/L) | 0.2 ± 0.02 a | 0.3 ± 0.1 a |
| Total Cholesterol (mg/dL) | 96.4 ± 4.1 a | 103.4 ± 5.2 a |
Blood was collected by tail vein nick (blood glucose) or from the trunk following a 6-h fast. Different letters denote significant differences between treatments. Shared letters are not significantly different from one another. Data are expressed as mean ± SEM (N = 7–8/group).